FDA/Industry Least Burdensome Collaboration To Follow Release Of Guidance
This article was originally published in The Gray Sheet
Executive Summary
FDA will meet with industry to discuss the agency's implementation of least burdensome requirements for premarket submissions, following the pending release of a draft guidance document.